BlackRock Global Funds - World Healthscience Fund D5 GBP IncRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 16.3 | 6.8 | -2.3 | 8.2 | |
+/-Cat | - | 6.9 | 11.5 | 0.8 | 4.4 | |
+/-B’mrk | - | -1.9 | 1.0 | 0.2 | 0.8 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 22/11/2024 | GBP 14.52 | |
Day Change | 2.40% | |
Morningstar Category™ | Sector Equity Healthcare | |
IA (formerly IMA) Sector | - | |
ISIN | LU2112292763 | |
Fund Size (Mil) 31/10/2024 | USD 14268.29 | |
Share Class Size (Mil) 22/11/2024 | GBP 39.00 | |
Max Initial Charge | - | |
Ongoing Charge 19/04/2024 | 1.03% |
Morningstar Research |
Analyst Report | 07/11/2024 Ramanand Kothari, Senior Analyst Morningstar, Inc |
A seasoned healthcare investor backed by a stable and well-resourced team underpins our conviction in BGF World Healthscience. The clean D share class retains its Morningstar Analyst Rating of Bronze, where other share classes range from Bronze... | |
Click here to read this analyst report on the underlying fund. |
Morningstar Pillars | |
---|---|
People | 24 |
Parent | 24 |
Process | 23 |
Performance | |
Price |
Investment Objective: BlackRock Global Funds - World Healthscience Fund D5 GBP Inc |
The Fund seeks to maximise total return and invest in a manner consistent with the principles of environmental, social and governance (“ESG”) investing. The Fund invests globally at least 70% of its total assets in the equity securities of companies whose predominant economic activity is in healthcare, pharmaceuticals, medical technology and supplies and the development of biotechnology. Currency exposure is flexibly managed. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Xiang Liu 01/06/2020 | ||
Erin Xie 01/04/2011 | ||
Inception Date 26/02/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BlackRock Global Funds - World Healthscience Fund D5 GBP Inc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 7.95 |
UnitedHealth Group Inc | Healthcare | 7.28 |
AbbVie Inc | Healthcare | 5.28 |
Boston Scientific Corp | Healthcare | 4.78 |
Novo Nordisk AS Class B | Healthcare | 4.66 |
Increase Decrease New since last portfolio | ||
BlackRock Global Funds - World Healthscience Fund D5 GBP Inc |